Implanet marked the first spinal surgeries performed in the U.S. with the ORIGIN cervical plate.
Following the acquisition of Orthopaedic & Spine Development with its Boston-based commercial subsidiary, Implanet was able to begin U.S. promotion of ORIGIN anterior cervical plates in late 2021. These plates have allowed Implanet to sign commercial agreements such as its partnership with ulrich medical in 2021.
Ludovic Lastennet, CEO of IMPLANET, added: “These first implantations are the consequence of the synergies resulting from our merger with OSD, reflecting the advantages of expanding our range of implants for spine surgery. We intend to build on this initial success and intensify our commercial approach, notably in the U.S.
“Our network of agents will now be able to present surgeons with an enhanced range that includes the ORIGIN cervical plate, which has CE Marking and FDA clearance. This first step should rapidly lead us to establish our offer on the American market in the field of cervical spine surgery, estimated at $1.35 billion with over 368,000 surgeries.”
Source: Implanet
Implanet marked the first spinal surgeries performed in the U.S. with the ORIGIN cervical plate.
Following the acquisition of Orthopaedic & Spine Development with its Boston-based commercial subsidiary, Implanet was able to begin U.S. promotion of ORIGIN anterior cervical plates in late 2021. These plates have allowed Implanet to sign...
Implanet marked the first spinal surgeries performed in the U.S. with the ORIGIN cervical plate.
Following the acquisition of Orthopaedic & Spine Development with its Boston-based commercial subsidiary, Implanet was able to begin U.S. promotion of ORIGIN anterior cervical plates in late 2021. These plates have allowed Implanet to sign commercial agreements such as its partnership with ulrich medical in 2021.
Ludovic Lastennet, CEO of IMPLANET, added: “These first implantations are the consequence of the synergies resulting from our merger with OSD, reflecting the advantages of expanding our range of implants for spine surgery. We intend to build on this initial success and intensify our commercial approach, notably in the U.S.
“Our network of agents will now be able to present surgeons with an enhanced range that includes the ORIGIN cervical plate, which has CE Marking and FDA clearance. This first step should rapidly lead us to establish our offer on the American market in the field of cervical spine surgery, estimated at $1.35 billion with over 368,000 surgeries.”
Source: Implanet
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
